Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors

[1]  A. Nicholson,et al.  [The Masaoka-Koga stage classification for thymic malignancies clarification and definition of terms]. , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[2]  F. Bosetti,et al.  The cyclooxygenase‐2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone‐induced demyelination , 2012, Journal of neurochemistry.

[3]  V. Guallar,et al.  Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax. , 2012, Biochemical pharmacology.

[4]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[5]  Anne-Marie C. Dingemans,et al.  MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer , 2011, PloS one.

[6]  G. Giaccone,et al.  Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry , 2011, Oncogene.

[7]  S. Gygi,et al.  SCFFbw7 Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction , 2010, Nature.

[8]  Yonghong Xiao,et al.  SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction , 2011 .

[9]  G. Giaccone,et al.  Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas , 2010, Cancer.

[10]  P. Meltzer,et al.  Expression and Mutational Status of c-kit in Thymic Epithelial Tumors , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  B. Schäfer,et al.  Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. , 2010, The Journal of clinical investigation.

[12]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[13]  Hai-rim Shin,et al.  Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. , 2009, Cancer genetics and cytogenetics.

[14]  N. Girard,et al.  Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas , 2009, Clinical Cancer Research.

[15]  G. Wilding,et al.  Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. , 2009, Chest.

[16]  A. Tangoku,et al.  Aberrant methylation of tumour-related genes in thymic epithelial tumours. , 2009, Lung cancer.

[17]  H. Dienemann,et al.  Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma , 2008, International journal of cancer.

[18]  C. Tse,et al.  Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models , 2008, Clinical Cancer Research.

[19]  G. Mazzini,et al.  Multi-parametric flow cytometric cell cycle analysis using TO-PRO-3 iodide (TP3): detailed protocols. , 2008, Acta histochemica.

[20]  Kotb Abdelmohsen,et al.  p16INK4a Translation Suppressed by miR-24 , 2008, PloS one.

[21]  W. Timens,et al.  Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. , 2008, European journal of cancer.

[22]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[23]  Laurent Bélec,et al.  Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis , 2007, Proceedings of the National Academy of Sciences.

[24]  G. Morgan,et al.  Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma , 2006, Leukemia.

[25]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[26]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[27]  A. Marx,et al.  Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. , 2004, The New England journal of medicine.

[28]  C. Pan,et al.  Expression of apoptosis‐related markers and HER‐2/neu in thymic epithelial tumours , 2003, Histopathology.

[29]  R. Penzel,et al.  Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka , 2003, International journal of cancer.

[30]  H. Müller-Hermelink,et al.  Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. , 2003, Cancer research.

[31]  A. D’Andrea,et al.  The Fanconi anaemia/BRCA pathway , 2003, Nature Reviews Cancer.

[32]  Y. Haga,et al.  Proliferative Activity and Apoptosis in Thymic Epithelial Neoplasms , 2002, Modern Pathology.

[33]  P. Lazarovici,et al.  Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. , 2001, Cancer research.

[34]  A. Rosenwald,et al.  Recurrent genetic aberrations in thymoma and thymic carcinoma. , 2000, The American journal of pathology.

[35]  S. Miyoshi,et al.  p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma , 1997, International journal of cancer.

[36]  K. Stefanaki,et al.  Expression of p53, mdm2, p21/waf1 and bcl‐2 proteins in thymomas , 1997, Histopathology.

[37]  Y. Jin,et al.  Immunohistochemical localization of Mcl‐1 and bcl‐2 proteins in thymic epithelial tumours , 1996, Histopathology.

[38]  Å. Borg,et al.  Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. , 1996, British Journal of Cancer.

[39]  R. Schreiber,et al.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.